The accurate, easy-to-deploy HRD test for labs | Datasheet English

The HRD test is a key biomarker to identify ovarian cancer patients likely to respond to PARP inhibitor (PARPi) therapy.

SeqOne offers a clinically validated HRD test designed specifically for efficient deployment in labs that want to deliver HRD tests in-house while offering following benefits: 

• Clinically validated performance
• Few inconclusive results
• Accurate, even with poor sample quality
• Easy to deploy and operate